Comparison of RNA-Based Next-Generation for Sequencing Assays for the Detection of NTRK Gene Fusions

被引:17
作者
Park, Hyeon J. [1 ]
Baek, Inji [1 ]
Cheang, Gloria [1 ]
Solomon, James P. [1 ]
Song, Wei [1 ]
机构
[1] Weill Cornell Med, Dept Lab Med & Pathol, 1300 York Ave LC 904, New York, NY 10065 USA
关键词
SOLID TUMORS; ONCOGENE;
D O I
10.1016/j.jmoldx.2021.07.027
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recently, the US Food and Drug Administration approved several targeted therapies directed against oncogenic fusions. One of the most effective such targeted therapies is Vitrakvi (larotrectinib), highly specific oral tropomyosin receptor kinase inhibitor indicated for the treatment of patients with any solid tumor harboring a fusion involving one of the neurotrophic receptor tyrosine kinase (NTRK) genes. Although several diagnostic approaches can be used to detect these NTRK fusions, RNA-based next-generation sequencing remains one of the most sensitive methods, as it can directly detect the transcribed end product of gene fusion at the mRNA level. In this study, performance characteristics of three RNA-based next-generation sequencing assays with distinct mechanisms and chemistries were investigated: anchored multiplex PCR, amplicon-based multiplex PCR, and hybrid capture-based enrichment method. Analytical sensitivity analysis shows that the amplicon-based multiplex PCR method has the lowest limit of detection. However, both hybrid-capture and anchored multiplex PCR methods can detect NTRK fusions with uncommon or novel fusion partners, which is challenging for the amplicon-based multiplex method. As for clinical sensitivity, all three methods were highly concordant in detecting NTRK fusions in patient samples. Additionally, they all presented equivalent high-level performance in specificity, suggesting that all three platforms can detect NTRK fusions in clinical samples with similar performance characteristics.
引用
收藏
页码:1443 / 1451
页数:9
相关论文
共 23 条
[1]   NTRK gene fusions as novel targets of cancer therapy across multiple tumour types [J].
Amatu, Alessio ;
Sartore-Bianchi, Andrea ;
Siena, Salvatore .
ESMO OPEN, 2016, 1 (02)
[2]   High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden [J].
Benayed, Ryma ;
Offin, Michael ;
Mullaney, Kerry ;
Sukhadia, Purvil ;
Rios, Kelly ;
Desmeules, Patrice ;
Ptashkin, Ryan ;
Won, Helen ;
Chang, Jason ;
Halpenny, Darragh ;
Schram, Alison M. ;
Rudin, Charles M. ;
Hyman, David M. ;
Arcila, Maria E. ;
Berger, Michael F. ;
Zehir, Ahmet ;
Kris, Mark G. ;
Drilon, Alexander ;
Ladanyi, Marc .
CLINICAL CANCER RESEARCH, 2019, 25 (15) :4712-4722
[3]   Accuracy of RNA-Seq and its dependence on sequencing depth [J].
Cai, Guoshuai ;
Li, Hua ;
Lu, Yue ;
Huang, Xuelin ;
Lee, Juhee ;
Mueller, Peter ;
Ji, Yuan ;
Liang, Shoudan .
BMC BIOINFORMATICS, 2012, 13 :S5
[4]   NTRK fusion-positive cancers and TRK inhibitor therapy [J].
Cocco, Emiliano ;
Scaltriti, Maurizio ;
Drilon, Alexander .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) :731-747
[5]   Identification of fusion genes in breast cancer by paired-end RNA-sequencing [J].
Edgren, Henrik ;
Murumagi, Astrid ;
Kangaspeska, Sara ;
Nicorici, Daniel ;
Hongisto, Vesa ;
Kleivi, Kristine ;
Rye, Inga H. ;
Nyberg, Sandra ;
Wolf, Maija ;
Borresen-Dale, Anne-Lise ;
Kallioniemi, Olli .
GENOME BIOLOGY, 2011, 12 (01)
[6]   Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer [J].
Farago, Anna F. ;
Azzoli, Christopher G. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (05) :550-559
[7]  
FDA, 2018, FDA Approves Larotrectinib for Solid Tumors with NTRK Gene Fusions
[8]   ONCOGENE ACTIVATION BY CHROMOSOME-TRANSLOCATION IN HUMAN MALIGNANCY [J].
HALUSKA, FG ;
TSUJIMOTO, Y ;
CROCE, CM .
ANNUAL REVIEW OF GENETICS, 1987, 21 :321-345
[9]   Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions [J].
Hechtman, Jaclyn F. ;
Benayed, Ryma ;
Hyman, David M. ;
Drilon, Alexander ;
Zehir, Ahmet ;
Frosina, Denise ;
Arcila, Maria E. ;
Dogan, Snjezana ;
Klimstra, David S. ;
Ladanyi, Marc ;
Jungbluth, Achim A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (11) :1547-1551
[10]   Targeting TRK family proteins in cancer [J].
Khotskaya, Yekaterina B. ;
Holla, Vijaykumar R. ;
Farago, Anna F. ;
Shaw, Kenna R. Mills ;
Meric-Bernstam, Funda ;
Hong, David S. .
PHARMACOLOGY & THERAPEUTICS, 2017, 173 :58-66